TMPO and nasopharyngeal carcinoma: Last but not least, Xing et al. [42] identified the novel TMPO-AS1/miR-320a/SOX4 pathway associated with nasopharyngeal carcinoma progression; interestingly, these authors suggested that TMPO-AS1 may be a potential therapeutic target for nasopharyngeal carcinoma.